Amgen Licenses Experimental Drug for Tuberculosis, Leprosy Treatment
Amgen Inc. has licensed one of its investigational pipeline drugs to Medicines Development for Global Health for the treatment of tuberculosis and leprosy.
More from California Business
North California Record
Following state appellate ruling involving ADA claims, further relief urged at federal level
California Business
•
Dec 5, 2022
FresnoBee | Business
Here's How to Keep Winter Utility Bills Down as Energy Costs Rise
California Business
•
Dec 5, 2022
East Bay Times | Business
Released Twitter emails show how employees debated how to handle 2020 New York Post Hunter Biden story
California Business
•
Dec 5, 2022